tradingkey.logo
tradingkey.logo
Search

OSR Holdings Inc

OSRH
Add to Watchlist
0.448USD
+0.018+4.19%
Close 07-31 16:00ETQuotes delayed by 15 min
14.92MMarket Cap
16.13P/E TTM

More Details of OSR Holdings Inc Company

OSR Holdings, Inc. is a global healthcare company, dedicated to advancing healthcare outcomes and improving the quality of life for people and their families. The Company is focused on building and developing a portfolio of transformative therapies and healthcare solutions. The Company's operating businesses (through its three wholly owned subsidiaries) include developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases and neurovascular intervention medical device and systems distribution in Korea. The Company’s subsidiary, Vaximm’s flagship asset, VXM01, is a late clinical-stage (NCT037500701) immuno-oncology candidate for glioblastoma. Vaximm has three clinical and pre-clinical drug candidates targeting diseases ranging from glioblastoma to gastrointestinal stromal tumor to ocular diseases. The Company has operations in Europe and South Korea.

OSR Holdings Inc Info

Ticker SymbolOSRH
Company nameOSR Holdings Inc
IPO dateFeb 10, 2023
CEOHwang (Kuk Hyoun)
Number of employees- -
Security typeOrdinary Share
Fiscal year-endFeb 10
Address10900 Ne 4Th Street, Suite 2300
CityBELLEVUE
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code98004
Phone14256357700
Websitehttps://osr-holdings.com/
Ticker SymbolOSRH
IPO dateFeb 10, 2023
CEOHwang (Kuk Hyoun)

Company Executives of OSR Holdings Inc

Name
Name/Position
Position
Shareholding
Change
Mr. Jin Whan Park
Mr. Jin Whan Park
Independent Director
Independent Director
20.00K
--
Mr. Kuk Hyoun (Peter) Hwang
Mr. Kuk Hyoun (Peter) Hwang
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
--
--
Mr. Jun Chul Whang
Mr. Jun Chul Whang
Chief Legal Officer, Company Secretary, Director
Chief Legal Officer, Company Secretary, Director
--
--
Mr. Phil Geon Lee
Mr. Phil Geon Lee
Lead Independent Director
Lead Independent Director
--
--
Mr. Gihyoun Bang
Mr. Gihyoun Bang
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Constance Hofer
Dr. Constance Hofer
Chief Scientific Officer
Chief Scientific Officer
--
--
Dr. Alcide Barberis, Ph.D.
Dr. Alcide Barberis, Ph.D.
Independent Director
Independent Director
--
--
Dr. Seng Chin Mah
Dr. Seng Chin Mah
Independent Director
Independent Director
--
--
Hyuk Joo Jee
Hyuk Joo Jee
Independent Director
Independent Director
--
--
Joong Myung Cho
Joong Myung Cho
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Jin Whan Park
Mr. Jin Whan Park
Independent Director
Independent Director
20.00K
--
Mr. Kuk Hyoun (Peter) Hwang
Mr. Kuk Hyoun (Peter) Hwang
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
--
--
Mr. Jun Chul Whang
Mr. Jun Chul Whang
Chief Legal Officer, Company Secretary, Director
Chief Legal Officer, Company Secretary, Director
--
--
Mr. Phil Geon Lee
Mr. Phil Geon Lee
Lead Independent Director
Lead Independent Director
--
--
Mr. Gihyoun Bang
Mr. Gihyoun Bang
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Constance Hofer
Dr. Constance Hofer
Chief Scientific Officer
Chief Scientific Officer
--
--

FAQs

Who are the top five shareholders of OSR Holdings Inc?

The top five shareholders of OSR Holdings Inc are: Mr. Jin Whan Park

How many institutions hold shares of OSR Holdings Inc (OSRH)?

As of 2026Q1, 43 institutions hold shares of OSR Holdings Inc, with a combined market value of approximately 220.68K, accounting for 0.67% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -3019653.00.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.